Defunct Company
Total Trials
4
As Lead Sponsor
As Collaborator
0
Total Enrollment
174
NCT03748758
Evaluation of Safety of Repeated Doses of OP0201 Metered Dose Inhaler Compared to Placebo in Healthy Adult Volunteers
Phase: Phase 1
Role: Lead Sponsor
Start: Nov 27, 2018
Completion: Mar 20, 2019
NCT03766373
Evaluation of Safety and Reduction of Ear Pain in Adults With Acute Otitis Media and Reduction of Ear Pain in Adults With Acute Otitis Media
Start: Jan 7, 2019
Completion: Jan 30, 2019
NCT03828149
Evaluation of Safety and Pharmacodynamics of OP0201 Compared to Placebo in Healthy Adults
Start: Feb 8, 2019
Completion: Mar 7, 2019
NCT03818815
A Study to Assess the Safety, Tolerability and Efficacy of OP0201 as an Adjunct Treatment for Acute Otitis Media in Infants and Children Aged 6 to 24 Months
Phase: Phase 2
Start: Feb 21, 2019
Completion: Mar 26, 2020